Georsua, Jelaica .
HRN: 28-71-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CEFTRIAXONE 1G (VIAL)
03/20/2026
03/27/2026
IV
2g
Q24h
Typhoid Fever
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: